Literature DB >> 12728186

Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients.

Shambhavi Venkataraman1, Richard C Semelka, Larissa Braga, Iona-Maria Danet, John T Woosley.   

Abstract

The purpose of this report is to describe the magnetic resonance (MR) imaging features of hepatic inflammatory myofibroblastic tumor (IMT). Two observers retrospectively analyzed images from six MR imaging examinations in four consecutive patients. Tumor location, size, extent, morphology, and number; signal intensity on nonenhanced images; enhancement pattern on serial gadolinium-enhanced images; duct wall thickness; and presence of biliary dilatation, vascular invasion, and lymphadenopathy were assessed. MR imaging findings were compared with histologic findings. On MR images, hepatic IMT manifested as a mass-like lesion in two patients and an area of periportal soft-tissue infiltration in three; one patient had both patterns. Because periportal infiltration is a common feature in both IMT and other malignant tumors of the porta hepatis, histologic examination should be considered before diagnosis and treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12728186     DOI: 10.1148/radiol.2273020572

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Unusual case of pancreatic inflammatory myofibroblastic tumor associated with spontaneous splenic rupture.

Authors:  Kamal S Hassan; Hector I Cohen; Fadi K Hassan; Shadi K Hassan
Journal:  World J Emerg Surg       Date:  2010-11-22       Impact factor: 5.469

Review 2.  Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases.

Authors:  E M Lopez-Tomassetti Fernandez; H Diaz Luis; A Martin Malagon; I Arteaga Gonzalez; A Carrillo Pallares
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Synchronous gastrointestinal and musculoskeletal manifestations of different subtypes of inflammatory myofibroblastic tumor: CT, MRI and pathological features.

Authors:  Marius Horger; Christina Pfannenberg; Michael Bitzer; Manfred Wehrmann; Claus D Claussen
Journal:  Eur Radiol       Date:  2004-08-21       Impact factor: 5.315

4.  Aggressive hilar inflammatory myofibroblastic tumor with hilar bile duct carcinoma in situ.

Authors:  Bum-Soo Kim; Sun-Hyung Joo; Gou-Young Kim; Kwang-Ro Joo
Journal:  J Korean Surg Soc       Date:  2011-11-25

5.  Inflammatory myofibroblastic tumour of the gallbladder.

Authors:  Kasim A Behranwala; Peter Straker; Andrew Wan; Cyril Fisher; Jeremy N Thompson
Journal:  World J Surg Oncol       Date:  2005-04-29       Impact factor: 2.754

6.  Uncommon hepatic tumors: iconographic essay - Part 2.

Authors:  Bruno Cheregati Pedrassa; Eduardo Lima da Rocha; Marcelo Longo Kierzenbaum; Renata Lilian Bormann; Viviane Vieira Francisc; Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2014 Nov-Dec

7.  Inflammatory myofibroblastic tumor of the liver mimicking an infiltrative malignancy in computed tomography and magnetic resonance imaging with Gd-EOB.

Authors:  Tahir Durmus; Carsten Kamphues; Hendrik Blaeker; Christian Grieser; Timm Denecke
Journal:  Acta Radiol Short Rep       Date:  2014-08-22

8.  MRI characteristics for the differential diagnosis of benign and malignant small solitary hypovascular hepatic nodules.

Authors:  Haizhen Qian; Shihong Li; Ming Ji; Guangwu Lin
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-07       Impact factor: 2.566

9.  Magnetic resonance imaging findings in primary lymphoma of the liver: a case report.

Authors:  Fatmir Bilaj; Leart Berdica; Arben Dhima; Gjergji Vreto
Journal:  J Med Case Rep       Date:  2012-09-05

10.  Follow-Up Imaging of Inflammatory Myofibroblastic Tumor of the Uterus and Its Spontaneous Regression.

Authors:  Biljana Markovic Vasiljkovic; Vesna Plesinac Karapandzic; Tomislav Pejcic; Aleksandra Djuric Stefanovic; Zorica Milosevic; Snezana Plesinac
Journal:  Iran J Radiol       Date:  2016-01-30       Impact factor: 0.212

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.